| Dr Nicholas J Manzari, MD | |
|
400 N Edwards St, Enterprise, AL 36330-2510 | |
| (334) 393-8701 | |
| Not Available |
| Full Name | Dr Nicholas J Manzari |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 38 Years |
| Location | 400 N Edwards St, Enterprise, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003856428 | NPI | - | NPPES |
| 009980545 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 00013879 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Medical Center South | Montgomery, AL | Hospital |
| Baptist Medical Center East | Montgomery, AL | Hospital |
| Prattville Baptist Hospital | Prattville, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Paragon Contracting Services Llc | 3971417825 | 264 |
News Archive
The COVID-19 pandemic is threatening to come back in greater intensity during the winter and fall. Faced with this threat, vaccine development efforts are entering a phase of renewed focus, attempting to identify antigens capable of eliciting protective levels of neutralizing antibodies. A new study published on the preprint server bioRxiv* in October 2020 reports on a novel mRNA vaccine candidate's performance in two animal models.
When a person has a brain injury due to a stroke or a trauma, they typically start in a hospital emergency room to treat any life threatening injuries. They are then often transferred to an inpatient rehabilitation program at the hospital where they receive intensive physical and cognitive therapy until they are well enough to transition home.
In a new study published in npj Digital Medicine, a team led by Child Mind Institute researchers report that a wearable tracking device they developed achieves higher accuracy in position tracking using thermal sensors in addition to inertial measurement and proximity sensors.
Maxygen, Inc. (Nasdaq:MAXY) today announced the consummation of the transactions contemplated by the previously announced joint venture agreement between Maxygen and Astellas Pharma Inc. Under the joint venture transaction, which closed on September 18, 2009, the parties established a newly-formed joint venture, Perseid Therapeutics LLC, to focus on the discovery, research and development of multiple protein pharmaceutical programs.
HEARTROID PROJECT and the TTDD lab at MIT today announced a creative partnership. HEARTROID platform, a catheter-based simulator, will participate in TTDD lab's effort of validating device performance with its pulsatile and anatomically precise 3D printed models, helping accelerate surgical device development from concept to testing.
› Verified 2 days ago
| Entity Name | Varicosity Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114968575 PECOS PAC ID: 3678541596 Enrollment ID: O20040920000248 |
News Archive
The COVID-19 pandemic is threatening to come back in greater intensity during the winter and fall. Faced with this threat, vaccine development efforts are entering a phase of renewed focus, attempting to identify antigens capable of eliciting protective levels of neutralizing antibodies. A new study published on the preprint server bioRxiv* in October 2020 reports on a novel mRNA vaccine candidate's performance in two animal models.
When a person has a brain injury due to a stroke or a trauma, they typically start in a hospital emergency room to treat any life threatening injuries. They are then often transferred to an inpatient rehabilitation program at the hospital where they receive intensive physical and cognitive therapy until they are well enough to transition home.
In a new study published in npj Digital Medicine, a team led by Child Mind Institute researchers report that a wearable tracking device they developed achieves higher accuracy in position tracking using thermal sensors in addition to inertial measurement and proximity sensors.
Maxygen, Inc. (Nasdaq:MAXY) today announced the consummation of the transactions contemplated by the previously announced joint venture agreement between Maxygen and Astellas Pharma Inc. Under the joint venture transaction, which closed on September 18, 2009, the parties established a newly-formed joint venture, Perseid Therapeutics LLC, to focus on the discovery, research and development of multiple protein pharmaceutical programs.
HEARTROID PROJECT and the TTDD lab at MIT today announced a creative partnership. HEARTROID platform, a catheter-based simulator, will participate in TTDD lab's effort of validating device performance with its pulsatile and anatomically precise 3D printed models, helping accelerate surgical device development from concept to testing.
› Verified 2 days ago
| Entity Name | Paragon Contracting Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225071459 PECOS PAC ID: 3971417825 Enrollment ID: O20050218000756 |
News Archive
The COVID-19 pandemic is threatening to come back in greater intensity during the winter and fall. Faced with this threat, vaccine development efforts are entering a phase of renewed focus, attempting to identify antigens capable of eliciting protective levels of neutralizing antibodies. A new study published on the preprint server bioRxiv* in October 2020 reports on a novel mRNA vaccine candidate's performance in two animal models.
When a person has a brain injury due to a stroke or a trauma, they typically start in a hospital emergency room to treat any life threatening injuries. They are then often transferred to an inpatient rehabilitation program at the hospital where they receive intensive physical and cognitive therapy until they are well enough to transition home.
In a new study published in npj Digital Medicine, a team led by Child Mind Institute researchers report that a wearable tracking device they developed achieves higher accuracy in position tracking using thermal sensors in addition to inertial measurement and proximity sensors.
Maxygen, Inc. (Nasdaq:MAXY) today announced the consummation of the transactions contemplated by the previously announced joint venture agreement between Maxygen and Astellas Pharma Inc. Under the joint venture transaction, which closed on September 18, 2009, the parties established a newly-formed joint venture, Perseid Therapeutics LLC, to focus on the discovery, research and development of multiple protein pharmaceutical programs.
HEARTROID PROJECT and the TTDD lab at MIT today announced a creative partnership. HEARTROID platform, a catheter-based simulator, will participate in TTDD lab's effort of validating device performance with its pulsatile and anatomically precise 3D printed models, helping accelerate surgical device development from concept to testing.
› Verified 2 days ago
| Entity Name | Southern Alabama Physicians, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467701490 PECOS PAC ID: 0345499562 Enrollment ID: O20121003000896 |
News Archive
The COVID-19 pandemic is threatening to come back in greater intensity during the winter and fall. Faced with this threat, vaccine development efforts are entering a phase of renewed focus, attempting to identify antigens capable of eliciting protective levels of neutralizing antibodies. A new study published on the preprint server bioRxiv* in October 2020 reports on a novel mRNA vaccine candidate's performance in two animal models.
When a person has a brain injury due to a stroke or a trauma, they typically start in a hospital emergency room to treat any life threatening injuries. They are then often transferred to an inpatient rehabilitation program at the hospital where they receive intensive physical and cognitive therapy until they are well enough to transition home.
In a new study published in npj Digital Medicine, a team led by Child Mind Institute researchers report that a wearable tracking device they developed achieves higher accuracy in position tracking using thermal sensors in addition to inertial measurement and proximity sensors.
Maxygen, Inc. (Nasdaq:MAXY) today announced the consummation of the transactions contemplated by the previously announced joint venture agreement between Maxygen and Astellas Pharma Inc. Under the joint venture transaction, which closed on September 18, 2009, the parties established a newly-formed joint venture, Perseid Therapeutics LLC, to focus on the discovery, research and development of multiple protein pharmaceutical programs.
HEARTROID PROJECT and the TTDD lab at MIT today announced a creative partnership. HEARTROID platform, a catheter-based simulator, will participate in TTDD lab's effort of validating device performance with its pulsatile and anatomically precise 3D printed models, helping accelerate surgical device development from concept to testing.
› Verified 2 days ago
| Entity Name | Emergency Services Of Montgomery Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528310323 PECOS PAC ID: 6608028204 Enrollment ID: O20121205000519 |
News Archive
The COVID-19 pandemic is threatening to come back in greater intensity during the winter and fall. Faced with this threat, vaccine development efforts are entering a phase of renewed focus, attempting to identify antigens capable of eliciting protective levels of neutralizing antibodies. A new study published on the preprint server bioRxiv* in October 2020 reports on a novel mRNA vaccine candidate's performance in two animal models.
When a person has a brain injury due to a stroke or a trauma, they typically start in a hospital emergency room to treat any life threatening injuries. They are then often transferred to an inpatient rehabilitation program at the hospital where they receive intensive physical and cognitive therapy until they are well enough to transition home.
In a new study published in npj Digital Medicine, a team led by Child Mind Institute researchers report that a wearable tracking device they developed achieves higher accuracy in position tracking using thermal sensors in addition to inertial measurement and proximity sensors.
Maxygen, Inc. (Nasdaq:MAXY) today announced the consummation of the transactions contemplated by the previously announced joint venture agreement between Maxygen and Astellas Pharma Inc. Under the joint venture transaction, which closed on September 18, 2009, the parties established a newly-formed joint venture, Perseid Therapeutics LLC, to focus on the discovery, research and development of multiple protein pharmaceutical programs.
HEARTROID PROJECT and the TTDD lab at MIT today announced a creative partnership. HEARTROID platform, a catheter-based simulator, will participate in TTDD lab's effort of validating device performance with its pulsatile and anatomically precise 3D printed models, helping accelerate surgical device development from concept to testing.
› Verified 2 days ago
| Entity Name | Mobile Emergency Physicians, Llc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881934982 PECOS PAC ID: 4981840832 Enrollment ID: O20130418000512 |
News Archive
The COVID-19 pandemic is threatening to come back in greater intensity during the winter and fall. Faced with this threat, vaccine development efforts are entering a phase of renewed focus, attempting to identify antigens capable of eliciting protective levels of neutralizing antibodies. A new study published on the preprint server bioRxiv* in October 2020 reports on a novel mRNA vaccine candidate's performance in two animal models.
When a person has a brain injury due to a stroke or a trauma, they typically start in a hospital emergency room to treat any life threatening injuries. They are then often transferred to an inpatient rehabilitation program at the hospital where they receive intensive physical and cognitive therapy until they are well enough to transition home.
In a new study published in npj Digital Medicine, a team led by Child Mind Institute researchers report that a wearable tracking device they developed achieves higher accuracy in position tracking using thermal sensors in addition to inertial measurement and proximity sensors.
Maxygen, Inc. (Nasdaq:MAXY) today announced the consummation of the transactions contemplated by the previously announced joint venture agreement between Maxygen and Astellas Pharma Inc. Under the joint venture transaction, which closed on September 18, 2009, the parties established a newly-formed joint venture, Perseid Therapeutics LLC, to focus on the discovery, research and development of multiple protein pharmaceutical programs.
HEARTROID PROJECT and the TTDD lab at MIT today announced a creative partnership. HEARTROID platform, a catheter-based simulator, will participate in TTDD lab's effort of validating device performance with its pulsatile and anatomically precise 3D printed models, helping accelerate surgical device development from concept to testing.
› Verified 2 days ago
| Entity Name | Hospital Physician Services - Southeast Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760410385 PECOS PAC ID: 5597774554 Enrollment ID: O20140219000913 |
News Archive
The COVID-19 pandemic is threatening to come back in greater intensity during the winter and fall. Faced with this threat, vaccine development efforts are entering a phase of renewed focus, attempting to identify antigens capable of eliciting protective levels of neutralizing antibodies. A new study published on the preprint server bioRxiv* in October 2020 reports on a novel mRNA vaccine candidate's performance in two animal models.
When a person has a brain injury due to a stroke or a trauma, they typically start in a hospital emergency room to treat any life threatening injuries. They are then often transferred to an inpatient rehabilitation program at the hospital where they receive intensive physical and cognitive therapy until they are well enough to transition home.
In a new study published in npj Digital Medicine, a team led by Child Mind Institute researchers report that a wearable tracking device they developed achieves higher accuracy in position tracking using thermal sensors in addition to inertial measurement and proximity sensors.
Maxygen, Inc. (Nasdaq:MAXY) today announced the consummation of the transactions contemplated by the previously announced joint venture agreement between Maxygen and Astellas Pharma Inc. Under the joint venture transaction, which closed on September 18, 2009, the parties established a newly-formed joint venture, Perseid Therapeutics LLC, to focus on the discovery, research and development of multiple protein pharmaceutical programs.
HEARTROID PROJECT and the TTDD lab at MIT today announced a creative partnership. HEARTROID platform, a catheter-based simulator, will participate in TTDD lab's effort of validating device performance with its pulsatile and anatomically precise 3D printed models, helping accelerate surgical device development from concept to testing.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nicholas J Manzari, MD 14050 Nw 14th St, Suite 190, Sunrise, FL 33323-2865 Ph: (800) 424-3672 | Dr Nicholas J Manzari, MD 400 N Edwards St, Enterprise, AL 36330-2510 Ph: (334) 393-8701 |
News Archive
The COVID-19 pandemic is threatening to come back in greater intensity during the winter and fall. Faced with this threat, vaccine development efforts are entering a phase of renewed focus, attempting to identify antigens capable of eliciting protective levels of neutralizing antibodies. A new study published on the preprint server bioRxiv* in October 2020 reports on a novel mRNA vaccine candidate's performance in two animal models.
When a person has a brain injury due to a stroke or a trauma, they typically start in a hospital emergency room to treat any life threatening injuries. They are then often transferred to an inpatient rehabilitation program at the hospital where they receive intensive physical and cognitive therapy until they are well enough to transition home.
In a new study published in npj Digital Medicine, a team led by Child Mind Institute researchers report that a wearable tracking device they developed achieves higher accuracy in position tracking using thermal sensors in addition to inertial measurement and proximity sensors.
Maxygen, Inc. (Nasdaq:MAXY) today announced the consummation of the transactions contemplated by the previously announced joint venture agreement between Maxygen and Astellas Pharma Inc. Under the joint venture transaction, which closed on September 18, 2009, the parties established a newly-formed joint venture, Perseid Therapeutics LLC, to focus on the discovery, research and development of multiple protein pharmaceutical programs.
HEARTROID PROJECT and the TTDD lab at MIT today announced a creative partnership. HEARTROID platform, a catheter-based simulator, will participate in TTDD lab's effort of validating device performance with its pulsatile and anatomically precise 3D printed models, helping accelerate surgical device development from concept to testing.
› Verified 2 days ago
Dr. Elray Jenkins, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 400 N Edwards St, Enterprise, AL 36330 Phone: 334-393-8701 | |
Dr. John Stanton, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Candlewood Dr, Enterprise, AL 36330 Phone: 215-802-9251 | |
Dr. John L Drew, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 400 N Edwards St, Enterprise, AL 36330 Phone: 334-393-8701 | |
Rick Alan Harrelson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Professional Lane, Enterprise, AL 36330 Phone: 334-347-3404 Fax: 334-693-0613 |